Penny Coulson
Institute of Cancer Research(GB)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Epigenetics and DNA Methylation, Virus-based gene therapy research, CRISPR and Genetic Engineering
Most-Cited Works
- → Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification(2019)105 cited
- → Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study(2018)98 cited
- → Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry(2021)96 cited
- → A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases(2019)94 cited
- → Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study(2014)84 cited
- → Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups(2016)78 cited
- → Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer(2015)71 cited
- → Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis(2015)56 cited
- → Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer(2015)51 cited
- → Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 + TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas(2021)40 cited